Gene · 10020
Papers4,261
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,261
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer. | Front Immunol | 2023 | 37885894 | PubTator, text mining | PubMed |
| Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy. | Pediatr Rheumatol Online J | 2023 | 37884945 | PubTator, text mining | PubMed |
| Approaches for disease prioritization and decision-making in animal health, 2000-2021: a structured scoping review. | Front Vet Sci | 2023 | 37876628 | PubTator, text mining | PubMed |
| CRISPR screening in hematology research: from bulk to single-cell level. | J Hematol Oncol | 2023 | 37875911 | PubTator, text mining | PubMed |
| The first case of a littoral spleen-preserving resection: a case report. | J Surg Case Rep | 2023 | 37867921 | PubTator, text mining | PubMed |
| Congenital disorders of glycosylation (CDG): state of the art in 2022. | Orphanet J Rare Dis | 2023 | 37858231 | PubTator, text mining | PubMed |
| MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders. | Neuromolecular Med | 2023 | 37856057 | PubTator, text mining | PubMed |
| Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era. | Front Oncol | 2023 | 37854680 | PubTator, text mining | PubMed |
| Case Report: A de novo NLRP3 variant resulting in autoinflammatory disease in a Chinese newborn. | Front Immunol | 2023 | 37854599 | PubTator, text mining | PubMed |
| Effect of immunology biomarkers associated with hip fracture and fracture risk in older adults. | Immun Ageing | 2023 | 37853468 | PubTator, text mining | PubMed |
| Pharmacokinetics and clinical efficacy of 6'-sialyllactose in patients with GNE myopathy: Randomized pilot trial. | Biomed Pharmacother | 2023 | 37852099 | PubTator, text mining | PubMed |
| The effect of workplace bullying on fatigue in school teachers: the moderating roles of gender and spirituality. | Libyan J Med | 2023 | 37851853 | PubTator, text mining | PubMed |
| Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial. | JMIR Res Protoc | 2023 | 37851498 | PubTator, text mining | PubMed |
| Activated platinum in gallium-based room-temperature liquid metals for enhanced reduction reactions. | RSC Adv | 2023 | 37849703 | PubTator, text mining | PubMed |
| Factors associated with retention of health workers in remote public health centers in Northern Uganda: a cross-sectional study. | Hum Resour Health | 2023 | 37848900 | PubTator, text mining | PubMed |
| CD44s-activated tPA/LRP1-NFκB pathway drives lamellipodia outgrowth in luminal-type breast cancer cells. | Front Cell Dev Biol | 2023 | 37842093 | PubTator, text mining | PubMed |
| Corpus callosum in children with neurodevelopmental delay: MRI standard qualitative assessment versus automatic quantitative analysis. | Eur Radiol Exp | 2023 | 37833469 | PubTator, text mining | PubMed |
| Bioinformatic analysis of m6A "reader" YTH family in pan-cancer as a clinical prognosis biomarker. | Sci Rep | 2023 | 37833468 | PubTator, text mining | PubMed |
| Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib. | Pediatr Rheumatol Online J | 2023 | 37828538 | PubTator, text mining | PubMed |
| Brain volumetric changes in menopausal women and its association with cognitive function: a structured review. | Front Aging Neurosci | 2023 | 37818479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10020/papers?page=12